AB Science S.A.
OTC: ABSCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Alain Moussy
- Employees
- 40
- Headquarters
- Paris, France
- IPO year
- 2011
- Market cap
- $78.1M
- Website
- https://www.ab-science.com
Loading ABSCF…
Loading profile data…Frequently asked questions about ABSCF
What does AB Science S.A. (ABSCF) do?
AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors, designed for applications in both human and animal medicine. The company's flagship product is masitinib, a tyrosine kinase inhibitor currently undergoing extensive Phase III clinical trials for a diverse range...
Where does ABSCF trade?
AB Science S.A. (ABSCF) trades on the Other OTC.
What sector is ABSCF in?
AB Science S.A. (ABSCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of AB Science S.A.?
Alain Moussy is the chief executive officer of AB Science S.A. (ABSCF).
Where is AB Science S.A. headquartered?
AB Science S.A. is headquartered in France.
Does ABSCF pay a dividend?
AB Science S.A. (ABSCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABSCF go public?
AB Science S.A. (ABSCF) completed its initial public offering in 2011.